
Rheumatologist

No OPD information available
Systemic Lupus Erythematosus (SLE)
Lupus Nephritis
Glomerulonephritis
Antiphospholipid Syndrome
Arthritis
Hyperaldosteronism
Hypertension
Meningitis
Metabolic Syndrome
Mouth Ulcers
Necrosis
Polyarteritis Nodosa
Vasculitis
Alberta Y. Hoi is a female medical professional who specializes in treating various conditions such as Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Glomerulonephritis, Antiphospholipid Syndrome, Arthritis, Hyperaldosteronism, Hypertension, Meningitis, Metabolic Syndrome, Mouth Ulcers, Necrosis, Polyarteritis Nodosa, and Vasculitis.
Alberta Y. Hoi helps patients with these health issues. She has special skills to provide the best care possible. She uses different treatments to help patients feel better and improve their health.
Patients trust Alberta Y. Hoi because she communicates well with them. She listens to their concerns and explains things clearly. Patients feel comfortable talking to her and know she cares about their well-being.
Alberta Y. Hoi stays updated with the latest medical knowledge and research. This helps her provide the most effective treatments to her patients. She always wants to learn more to give the best care possible.
Alberta Y. Hoi works well with other medical professionals. She has good relationships with her colleagues and collaborates with them to ensure patients receive comprehensive care. Teamwork is important to her, and she values working together with others.
Alberta Y. Hoi's work has positively impacted many patients' lives. Her treatments have helped people feel better and improve their health. Patients are grateful for the care and support they receive from Alberta Y. Hoi.
One of Alberta Y. Hoi's notable publications is "Evaluation of primary aldosteronism testing in hypertensive patients with SLE in a tertiary hospital" published in Lupus science & medicine. She has also been involved in clinical trials to improve treatments for patients with Systemic Lupus Erythematosus.
In summary, Alberta Y. Hoi is a dedicated medical professional who provides excellent care to her patients, stays updated with medical knowledge, collaborates with colleagues, and positively impacts patients' lives through her work.
Enrollment Status: Terminated
Published: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
